As published in Frontiers in Pharmacology, the biopharmaceutical drug development firm's sponsored research has identified and validated cannabinoid ratio-controlled, Minimum Essential Mixtures (MEM) for the treatment of Parkinson's disease symptoms
Read Press ReleaseGerman-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.
Read Press ReleaseA sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.
Read Press ReleaseNonsurgical spinal decompression treatment device - Spine MT - was verified of its effectiveness for disc treatment and was proposed as a conservative treatment method for patients with spinal disc disease.
Read Press ReleaseThe new Ethical eDSMB® software provides sponsors, CROs and AROs with a comprehensive solution for easier and more efficient DSMB, DMC and Steering Committee management. With eAdjudication® for clinical adjudication, eDeviation® for protocol deviations, and now eDSMB® for DSMBs, DMCs and Steering Committees, Ethical's customers have access to a full range of easy-to-use software platforms for managing clinical committees in a more efficient way.
Read Press ReleaseThe QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).
Read Press ReleaseGb Sciences is focusing considerable resources on bringing its lead Parkinson's disease formulations to the clinic with promising results; plus, new data validating the efficacy of their novel anxiety formulations and demonstrating the improved stability of their oral nanoparticle-encapsulated chronic pain formulations add value to their drug development pipeline.
Read Press ReleaseAt a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
Read Press ReleaseIn collaboration with Swiss precision manufacturer CSEM, 3Brain AG has announced an exciting 3D microchip for their brain-on-chip portfolio. This first-in-class cell-electronic interface technology will allow scientists to study the complexity of 3D cellular networks at unrivalled scale and precision - and to gain novel mechanistic insights into the inner workings of the most complex structure in the universe: the human brain.
Read Press ReleaseAccuro's integration of artificial intelligence with ultrasound (AI-US) provides detailed ultrasound image analysis pivotal in complex clinical scenarios.
Read Press ReleaseAfter months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.
Read Press Releasesam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.
Read Press ReleaseAs digitization becomes a necessity in the life sciences industry, Gb Sciences proves it's already ahead of the curve with its own revolutionary technology.
Read Press ReleaseAs digitization becomes a necessity in the life sciences industry, Gb Sciences proves it's already ahead of the curve with its own revolutionary technology.
Read Press ReleaseAmerican Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American Society of Hematology (ASH), the Center of International Blood and Marrow Transplant Research (CIBMTR), and ASTCT to receive the ASH-CIBMTR-ASTCT Career Development Award.
Read Press ReleasePharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest continuous score for the quantification of the severity of fibrosis and treatment effects of NASH therapies at the 2022 International Liver Conference.
Read Press ReleasePureWay® launches safe and environmentally friendly medical waste solutions for pharmaceutical, biotech and medical device manufacturers.
Read Press ReleaseAmerican Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
Read Press ReleaseTests to identify chromosomal abnormalities in embryos and in early pregnancies rely on outdated science. Regulation of these genetic tests is urgently needed to ensure transparency and validation.
Read Press Release